Sensory Profile of People With High Intellectual Potential (HIP)
NCT ID: NCT07072455
Last Updated: 2025-07-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
160 participants
OBSERVATIONAL
2025-04-01
2027-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study involves the collection of data associated with High Intellectual Potential characteristics, sensory profile, and includes clinical measures such as anxiety anxiety, autistic traits and coping in High Intellectual Potential and control participants.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Gesture and Executive Functions in Children With High Intellectual Potential
NCT03128125
Assessment of the Psychological, Cognitive and Social Resources of Applicants for Huntington's Disease and Presymptomatic Genetic Testing
NCT02134561
Neurophysiological Study of Sensory and Cognitive Processes in Healthy Children and Adults
NCT03182400
Study of Attentional Disorders in Patients Suffering From Idiopathic Generalized Epilepsy.
NCT05530109
Neural Mechanisms of Sensory Processing Anomalies
NCT06234033
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High Intellectual Potential
Subjects with a High Intellectual Potential : Cognitive assessment using the Wechsler Adult Intelligence Scale (WAIS-III or WAIS-IV) scale or Wechsler Intelligence Scale for Children (WISC-VI or WISC-V) scale by a psychologist.
Intelligence Quotient (IQ) ≥ 130, in the case of a homogeneous cognitive profile, or General Aptitude Index (GAI) ≥ 130 \[124-134\], in the case of a heterogeneous cognitive profile
Scales
This observational study consists of data collection using a structured questionnaire based on an e-CRF, distributed by e-mail.
Four questionnaires were administered : the Revised Ritvo Autism and Asperger Diagnostic Scale (RAADS-R-Fr), the Adolescent/Adult Sensory Profile (AASP), the Coping Inventory for Stressful Situations (CISS) and the State-Trait Anxiety Inventory (STAI-Y).
Socio-demographic and treatments were collected.
High Intellectual Potential Scale
For participants with High Intellectual Potential, the total Intelligence Quotient (IQ) or General Ability Index (GAI), along with the index scores from the Wechsler scales (Verbal Comprehension Index, Perceptual Reasoning Index, Working Memory Index, and Processing Speed Index), will be extracted from the cognitive assessment previously completed by the participant prior to study enrollment.
Control
Subjects whitout High Intellectual Potential
Scales
This observational study consists of data collection using a structured questionnaire based on an e-CRF, distributed by e-mail.
Four questionnaires were administered : the Revised Ritvo Autism and Asperger Diagnostic Scale (RAADS-R-Fr), the Adolescent/Adult Sensory Profile (AASP), the Coping Inventory for Stressful Situations (CISS) and the State-Trait Anxiety Inventory (STAI-Y).
Socio-demographic and treatments were collected.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Scales
This observational study consists of data collection using a structured questionnaire based on an e-CRF, distributed by e-mail.
Four questionnaires were administered : the Revised Ritvo Autism and Asperger Diagnostic Scale (RAADS-R-Fr), the Adolescent/Adult Sensory Profile (AASP), the Coping Inventory for Stressful Situations (CISS) and the State-Trait Anxiety Inventory (STAI-Y).
Socio-demographic and treatments were collected.
High Intellectual Potential Scale
For participants with High Intellectual Potential, the total Intelligence Quotient (IQ) or General Ability Index (GAI), along with the index scores from the Wechsler scales (Verbal Comprehension Index, Perceptual Reasoning Index, Working Memory Index, and Processing Speed Index), will be extracted from the cognitive assessment previously completed by the participant prior to study enrollment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants with a High Intellectual Potential : Cognitive assessment using the WAIS or WISC-V scale by a psychologist; Intelligence Quotient (IQ) ≥ 130, in the case of a homogeneous cognitive profile, or General Aptitude Index (GAI) \> 130 \[124-134\], in the case of a heterogeneous cognitive profile
* Gender and Age: Male or female, aged 18 to 65
* Consent: Free, informed, and written consent (e-CRF)
* Control :
* Gender and Age: Male or female, aged 18 to 65
* Consent: Free, informed, and written consent (e-CRF)
Exclusion Criteria
* History or declared psychiatric disorder (characterized depressive episode, personality disorder, addiction, eating disorder, bipolar disorder, obsessive-compulsive disorder)
* Neurodevelopmental disorders (autism spectrum disorder, attention deficit and hyperactivity disorder , developmental coordination disorder)
* Sensory disability
* Subjects under guardianship or curatorship
* Pregnant or breast-feeding women
* Control :
* Presence of High Intellectual Potential known
* Presence of intellectual development disorder
* History or declared psychiatric disorder (characterized depressive episode, personality disorder, addiction, eating disorder, bipolar disorder, obsessive-compulsive disorder)
* Neurodevelopmental disorders (autism spectrum disorder, attention deficit and hyperactivity disorder , developmental coordination disorder)
* Sensory disability
* Subjects under guardianship or curatorship
* Pregnant or breast-feeding women
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Esquirol
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aude Paquet
Psychomotor Therapist, Doctor in Psychology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Esquirol Hospital Center
Limoges, Nouvelle-Aquitaine, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-A02488-39
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.